(Q50489370)

14 March 2018

title

Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. (English)

1 reference

14 March 2018

0 references

0 references

6

1 reference

14 March 2018

José Luis Molinuevo

8

1 reference

14 March 2018

Ramon Trullas

10

1 reference

14 March 2018

Petar Podlesniy

object named as

Petar Podlesniy

1

0 references

Raquel Sanchez-Valle

object named as

Raquel Sanchez-Valle

5

0 references

author name string

Joana Figueiro-Silva

2

1 reference

14 March 2018

Albert Llado

3

1 reference

14 March 2018

Anna Antonell

4

1 reference

14 March 2018

Alberto Lleo

7

1 reference

14 March 2018

Nuria Serra

9

1 reference

14 March 2018

publication date

4 September 2013

1 reference

14 March 2018

published in

Annals of Neurology

1 reference

14 March 2018

volume

74

1 reference

14 March 2018

issue

5

1 reference

14 March 2018

page(s)

655-668

1 reference

14 March 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

cites work

1 reference

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

21 January 2018

1 reference

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

21 January 2018

1 reference

Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

21 January 2018

1 reference

Neuropathology of older persons without cognitive impairment from two community-based studies

21 January 2018

1 reference

CSF biomarkers in neurodegenerative diseases.

21 January 2018

1 reference

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

CSF biomarkers in frontotemporal lobar degeneration with known pathology

21 January 2018

1 reference

A mitochondrial etiology of Alzheimer and Parkinson disease

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

21 January 2018

1 reference

The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number

21 January 2018

1 reference

DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination

21 January 2018

1 reference

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria

21 January 2018

1 reference

Mitochondrial γ‐secretase participates in the metabolism of mitochondria‐associated amyloid precursor protein

21 January 2018

1 reference

Bioenergetic origins of complexity and disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.23955

1 reference

14 March 2018

1 reference

14 March 2018